Healthcare
Incyte Corporation (INCY)
Incyte Corporation stock analysis and opportunity scoring
$121.47
↓ -1.47%
Incyte Corporation (INCY) at a glance
Incyte Corporation (INCY) is a publicly traded company in the Healthcare - Biotechnology sector tracked by MKD Intelligence.
INCY last traded at $120.16 as of 2026-09-15.
MKD Intelligence assigns INCY a composite opportunity score of 39 out of 100, indicating cautious conditions across trend, momentum and volume factors.
The risk score for INCY is 36 out of 100 (moderate), where a higher number means greater expected volatility.
Price History
High
$129.72
Low
$120.16
Period
Sep 11 - Aug 14 (20d)
Hover for details • Scroll to zoom • Drag to pan • Double-click to reset
Recent News
No recent news available.
Upcoming Events
Data as of Sep 15
This platform provides market intelligence and educational information only. It does not constitute financial advice, and no information presented should be interpreted as a recommendation to buy, sell, or hold any security. Past performance and historical patterns do not guarantee future results.
